Last reviewed · How we verify

Propofol : TCI Schnider

Pr Isabelle CONSTANT · Phase 1 active Small molecule

Propofol : TCI Schnider is a Small molecule drug developed by Pr Isabelle CONSTANT. It is currently in Phase 1 development.

At a glance

Generic namePropofol : TCI Schnider
SponsorPr Isabelle CONSTANT
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Propofol : TCI Schnider

What is Propofol : TCI Schnider?

Propofol : TCI Schnider is a Small molecule drug developed by Pr Isabelle CONSTANT.

Who makes Propofol : TCI Schnider?

Propofol : TCI Schnider is developed by Pr Isabelle CONSTANT (see full Pr Isabelle CONSTANT pipeline at /company/pr-isabelle-constant).

What development phase is Propofol : TCI Schnider in?

Propofol : TCI Schnider is in Phase 1.

Related